The U.S. Food and Drug Administration’s (FDA) has released a new plan to leverage novel data sources and advanced data analytics to identify current and emerging safety vulnerabilities in the "Cannabis-Derived Products" market.
The plan addresses CBD and other emerging cannabinoids such as delta-8-...
read more